NeuroVive Pharmaceutical AB Bargeld je Aktie
Was ist das Bargeld je Aktie von NeuroVive Pharmaceutical AB?
Bargeld je Aktie von NeuroVive Pharmaceutical AB ist 0.29
Was ist die Definition von Bargeld je Aktie?
Barmittel pro Aktie ist der Kassenbestand eines Unternehmens, geteilt durch die ausstehenden Aktien des Unternehmens.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Bargeld je Aktie von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu NeuroVive Pharmaceutical AB
Was macht NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Unternehmen mit bargeld je aktie ähnlich NeuroVive Pharmaceutical AB
- Almadex Minerals hat Bargeld je Aktie von 0.29
- Tongdao Liepin hat Bargeld je Aktie von 0.29
- Courage Investment hat Bargeld je Aktie von 0.29
- AGBA Acquisition hat Bargeld je Aktie von 0.29
- S&T hat Bargeld je Aktie von 0.29
- DWS hat Bargeld je Aktie von 0.29
- NeuroVive Pharmaceutical AB hat Bargeld je Aktie von 0.29
- Desert Mountain hat Bargeld je Aktie von 0.29
- ServiceSource International Inc hat Bargeld je Aktie von 0.29
- China Jo-Jo Drugstores Inc hat Bargeld je Aktie von 0.29
- Zoom Telephonics hat Bargeld je Aktie von 0.29
- RattanIndia Infrastructure hat Bargeld je Aktie von 0.29
- Pact Ltd hat Bargeld je Aktie von 0.30